Irish firm offering cybersecurity risk management tools for medical device manufacturers and healthcare providers.
Nova Leah Ltd. was founded in 2015 in Ireland and is led by CEO Anita Finnegan, who co-founded it with Fergal Caffery and Peter Finnegan. Its SelectEvidence and SelectEvaluate platforms help device makers meet FDA cybersecurity requirements and help healthcare providers assess third-party vendor risk. The company operates mainly on subscriptions sold business to business in the United States and Europe. In December 2021 it raised EUR 2.15 million in seed funding led by Northwell Ventures, with Kernel Capital and Sure Valley Ventures also participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in